Sheri D. Schully, Ph.D.
Knowledge Integration Team Lead, Office of the Associate Director
- Telephone: (240) 276-6936
- Fax: (240) 276-7921
- E-mail: firstname.lastname@example.org
Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E106, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)
- Using the tools of Knowledge Integration to uncover what is known or unknown about cancer epidemiology
- Translation of genome-based knowledge and technologies to improve population health and the use of biospecimens in research
- Ph.D. - Biological Sciences
Louisiana State University
- B.S. - Zoology, with a minor in Chemistry
Louisiana State University
Dr. Schully is Team Lead for the Knowledge Integration Team in the Epidemiology and Genomics Research Program's (EGRP) Office of the Associate Director. She was previously a Program Director in EGRP's Host Susceptibility Factors Branch (now the Genomic Epidemiology Branch). Dr. Schully's responsibilities include systematically managing the accumulating knowledge base and tools for cancer epidemiology and genomics to accelerate research, evidence-based recommendations, and translation into prevention and clinical practice. She led the development of the Cancer Genomics and Epidemiology Navigator (CGEN), an integrated, searchable and updated knowledge base on the impact of genomic, environmental and clinical factors on cancer occurrence and outcomes. Dr. Schully is also the Program Officer for the Breast Cancer Family Registry and the Colon Cancer Family Registry cohorts and she helps coordinate the EGRP webinar series, Transforming Epidemiology through Advanced Methods (TEAM).
In addition to leading the Knowledge Integration team, Dr. Schully is heavily involved in Public Health Genomics research which involves translating genomic discoveries into clinical care and to make a population health impact. She collaborates very closely with the Centers for Disease Control and Prevention's Office of Public Health Genomics. She is closely involved with the National Human Genome Research Institute's Clinical Genomics (CLinGen) Resource and Clinical Sequencing Exploratory Research (CSER) Program and serves on the steering committees of both groups.
Dr. Schully joined NCI in 2005 as a Presidential Management Fellow through which she completed several rotations in various NCI Divisions and Offices, including with EGRP, the Division of Cancer Epidemiology and Genetics (DCEG), and the Small Business Innovation Research Program within the Office of the Director. During these rotations, Dr. Schully worked with the Cancer Family Registries (CFRs) and organized activities for the Cancer Genetic Markers of Susceptibility Initiative. During her time as a Presidential Management Fellow, Dr. Schully also served as an intern with C-Change, a non-profit organization comprised of the nation's key cancer leaders from government, business, and non-profit sectors.
Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. J Natl Cancer Inst. 2015 Feb 16;107(4).
Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ. Evidence synthesis and guideline development in genomic medicine: current status and future prospects. Genet Med. 2015 Jan;17(1):63-7.
Schully SD, Rogers SD, Lam TK, Chang CQ, Clyne M, Cyr J, Watson D, Khoury MJ. The Cancer Genomics and Epidemiology Navigator: An NCI online tool to enhance cancer epidemiology research. Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2610-1.
Chang CQ, Tingle SR, Filipski KK, Khoury MJ, Lam TK, Schully SD, Ioannidis JP. An overview of recommendations and translational milestones for genomic tests in cancer. Genet Med. 2014 Oct 23. [Epub ahead of print]
Carrick DM, Mette E, Hoyle B, Rogers SD, Gillanders EM, Schully SD, Mechanic LE. The use of biospecimens in population-based research: a review of the National Cancer Institute's Division of Cancer Control and Population Sciences grant portfolio. Biopreserv Biobank. 2014 Aug;12(4):240-5.
Marrone M, Filipski KK, Gillanders EM, Schully SD, Freedman AN. Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies. PLoS Curr. 2014 May 27;6. pii: ecurrents.eogt.aa5415d435fc886145bd7137a280a971.
Shaikh AR, Butte AJ, Schully SD, Dalton WS, Khoury MJ, Hesse BW. Collaborative biomedicine in the age of big data: the case of cancer. J Med Internet Res. 2014 Apr 7;16(4):e101. doi: 10.2196/jmir.2496.
Dotson WD, Douglas MP, Kolor K, Stewart AC, Bowen MS, Gwinn M, Wulf A, Anders HM, Chang CQ, Clyne M, Lam TK, Schully SD, Marrone M, Feero WG, Khoury MJ. Prioritizing genomic applications for action by level of evidence: a horizon-scanning method. Clin Pharmacol Ther. 2014 Apr;95(4):394-402.
Chang CQ, Yesupriya A, Rowell JL, Pimentel CB, Clyne M, Gwinn M, Khoury MJ, Wulf A, Schully SD. A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes. Eur J Hum Genet. 2014 Mar;22(3):402-8.
Clyne M, Schully SD, Dotson WD, Douglas MP, Gwinn M, Kolor K, Wulf A, Bowen MS, Khoury MJ. Horizon scanning for translational genomic research beyond bench to bedside. Genet Med. 2014 Jan 9 [Epub ahead of print].
Ioannidis JP, Zhou Y, Chang CQ, Schully SD, Khoury MJ, Freedman AN. Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses. Ann Oncol. 2014 Jan;25(1):16-23.
Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):508-16.
Lam TK, Spitz M, Schully SD, Khoury MJ. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):181-8.
Ioannidis JP, Schully SD, Lam TK, Khoury MJ. Knowledge integration in cancer: current landscape and future prospects. Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):3-10.
Khoury MJ, Coates RJ, Fennell ML, Glasgow RE, Scheuner MT, Schully SD, Williams MS, Clauser SB. Multilevel research and the challenges of implementing genomic medicine. J Natl Cancer Inst Monogr. 2012 May;2012(44):112-20.
Khoury MJ, Gwinn M, Dotson WD, Schully SD. Knowledge integration at the center of genomic medicine. Genet Med. 2012 Jul;14(7):643-7.
Schully SD, Deverka PA, Ishibe N, Carlson JJ, Freedman A, Goddard KA, Khoury MJ, Ramsey SD. Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies. Genet Med. 2012 Jul;14(7):656-62. Erratum in: Genet Med. 2013 Jan;15(1):91.
Schully SD, Benedicto CB, Khoury MJ. How can we stimulate translational research in cancer genomics beyond bench to bedside? Genet Med. 2012 Jan;14(1):169-70.
Schully SD, Yu W, McCallum V, Benedicto CB, Dong LM, Wulf A, Clyne M, Khoury MJ. Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies. Eur J Hum Genet. 2011 Aug;19(8):928-30.
Schully SD, Benedicto CB, Gillanders EM, Wang SS, Khoury MJ. Translational Research in Cancer Genetics: The Road Less Travelled. Public Health Genomics: 2011;14(1):1-8. Epub 2009 Dec 29.